the Efficacy and Safety of Sugammadex in Children 0-2 Years Old

Conditions:   Anesthesia;   Pediatric Cancer;   Pediatric Tumor;   Pediatric Hepatoblastoma;   Beta-Thalassemia;   Hepatic Metastases Intervention:   Drug: Sugammadex Sponsor:   Federal Research Institute of Pediatric Hematology, Oncology and Immunology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials